February 2026
1. CALEJERO I, Mobarki M, Musawi S, Peoc'h M, et al
   The molecular profile of ovarian struma ovarii.
   Hum Pathol. 2026;171:106069.
   

   >> Share

   
   
2. ZHANG Z, Feng P, Ge Z, Liang Z, et al
   PIK3R1 acts as a prominent biomarker for tumor immune microenvironment modulation in intravenous leiomyomatosis.
   Hum Pathol. 2026;168:106002.
   

   >> Share

   
   January 2026
3. YANG Y, Sun S, Xi Y, Xu C, et al
   Correlation analysis of TP53 missense mutations and p53 protein expression patterns in endometrial carcinoma.
   Hum Pathol. 2026;171:106056.
   

   >> Share

   
   December 2025
4. NAM GH, Tan HM, Quddus MR, Dong J, et al
   Endometrial Gastric (Gastrointestinal)-type Mucinous Adenocarcinoma: Diagnostic Criteria, Differential Diagnosis, and Molecular Insights.
   Hum Pathol. 2025 Dec 29:106031. doi: 10.1016/j.humpath.2025.106031.
   

   >> Share

   
   
5. BUZA N, Sun T, Hui P
   Endometrial Carcinomas - Challenges and Updates on Selected Topics.
   Hum Pathol. 2025 Dec 11:106016. doi: 10.1016/j.humpath.2025.106016.
   

   >> Share

   
   
6. YANG F, Liu Y, Wang Y, Yang J, et al
   Ovarian GLI1 fusion tumors Mimicking Sex Cord-Stromal Tumors: Clinicopathological and Molecular Characterization of a Five-Case Series.
   Hum Pathol. 2025 Dec 9:106003. doi: 10.1016/j.humpath.2025.106003.
   

   >> Share

   
   
7. XI Y, He C, Fang X, Yin JC, et al
   Analysis of Discordance between Mismatch Repair and Microsatellite Instability Testing in Endometrial Cancer.
   Hum Pathol. 2025 Dec 8:106004. doi: 10.1016/j.humpath.2025.106004.
   

   >> Share

   
   October 2025
8. SCHOOLMEESTER JK, Hodge JC, Swanson AA
   HMGA2 and RB1 profiling in uterine and broad ligament leiomyomas with adipocytic differentiation: An immunohistochemical and fluorescence in situ hybridization study of 14 conventional and variant lipoleiomyomas.
   Hum Pathol. 2025 Oct 12:105950. doi: 10.1016/j.humpath.2025.105950.
   

   >> Share

   
   
9. HOHN AK, Hiller GGR, Wolf B, Forberger M, et al
   Assessment of Nectin4-expression in vulvar squamous cell carcinomas (VSCC): correlation with HPV-associated and HPV-independent molecular subtypes.
   Hum Pathol. 2025;164:105926.
   

   >> Share

   
   August 2025
10. QIN L, Lin W, Huang S, Zheng W, et al
    High-grade endometrioid carcinomas with pilomatrix-like features lacking CTNNB1 Mutations: Clinicopathologic characteristics and novel molecular events.
    Hum Pathol. 2025;164:105928.
    

    >> Share

    
    July 2025
11. LEENEN S, Kooreman L, Bulten J, Esch EMGV, et al
    The occurrence and histopathological recognition of atypical endometriosis in patients with ovarian endometriosis - a retrospective cohort study.
    Hum Pathol. 2025 Jul 22:105875. doi: 10.1016/j.humpath.2025.105875.
    

    >> Share

    
    June 2025
12. LEI T, Liu B, Wei Y, Shi Y, et al
    Female reproductive tract inflammatory myofibroblastic tumor (IMT): A comprehensive analysis of clinicopathological and genomic features in a case series, including the identification of SERPINE1-ALK fusion in the fallopian tube.
    Hum Pathol. 2025;160:105839.
    

    >> Share

    
    
13. ZHONG F, Ren Z, Li W, Jones T, et al
    The sensitivity and specificity of Claudin18.2 and MUC6 in the differential diagnosis of endocervical gastric-type glandular lesions.
    Hum Pathol. 2025;160:105837.
    

    >> Share

    
    May 2025
14. TEKIN B, Cheville JC, Milosevic D, McCarthy M, et al
    Assessment of trophoblast cell-surface antigen 2 (TROP2) and nectin-4 expression in choriocarcinoma.
    Hum Pathol. 2025;159:105815.
    

    >> Share

    
    
15. ZHANG Y, Karimi SS, Requena DO, Khararjian A, et al
    Intestinal and liver involvement by endometrial stromal sarcoma: Expanding the differential diagnosis of mesenchymal tumors involving the GI tract.
    Hum Pathol. 2025;158:105784.
    

    >> Share

    
    
16. MILLER CH, Vemuri A, Lengyel E, Lastra RR, et al
    Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score.
    Hum Pathol. 2025;159:105800.
    

    >> Share

    
    March 2025
17. HE D, Jin L, Geng H, Cao L, et al
    Deep learning-based analysis of gross features for ovarian epithelial tumors classification: A tool to assist pathologists for frozen section sampling.
    Hum Pathol. 2025;157:105762.
    

    >> Share

    
    
18. ZHANG Z, Shi H, Shao Y, Lu B, et al
    Clinicopathologic and molecular characterization of primitive neuroectodermal tumors (PNET) in the female genital tract: a retrospective study of 8 cases.
    Hum Pathol. 2025;157:105769.
    

    >> Share

    
    
19. ZHENG L, Tabet G, Guo CC, Rizvi YO, et al
    Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX 17 in its differential diagnosis.
    Hum Pathol. 2025;157:105767.
    

    >> Share

    
    January 2025
20. NODA Y, Tokuyama Y, Sumita W, Kita M, et al
    Hepatocyte nuclear factor 4alpha as a sensitive marker for uterine endocervical adenocarcinomas and their precursors.
    Hum Pathol. 2025;155:105714.
    

    >> Share

    
    
21. SCHOOLMEESTER JK, Gupta S, Boland JM, Al Kateb H, et al
    Ovarian Epithelioid Tumor with FUS::CREM Fusion and Multilineage Protein Expression: Report of a Case in the EWSR1/FUS-CREB Tumor Spectrum.
    Hum Pathol. 2025 Jan 8:105712. doi: 10.1016/j.humpath.2024.105712.
    

    >> Share

    
    December 2024
22. KHAEFPANAH D, Zare S, Hasteh F, Shi WJ, et al
    Characterization of gastric/gastrointestinal-like immunophenotypes in endometrial endometrioid adenocarcinomas, including endometrioid adenocarcinomas with mucinous differentiation.
    Hum Pathol. 2024;154:105707.
    

    >> Share

    
    
23. ZHANG Y, Ju B, Cheng R, Ding T, et al
    PD-L1 expression and immune infiltration across molecular subtypes of endometrial cancer: An integrative-analysis of molecular classification and immune subtypes.
    Hum Pathol. 2024;154:105704.
    

    >> Share

    
    November 2024
24. ACOSTA AM, Fletcher CDM, Sholl LM, van Leenders GJ, et al
    Fluorescence in-situ hybridization assessment of spindle cell-rich testicular sex cord stromal tumors demonstrates multiple chromosomal gains across histologic subtypes.
    Hum Pathol. 2024;153:105652.
    

    >> Share

    
    October 2024
25. BROUARD M, Mobarki M, Peoc'h M, Karpathiou G, et al
    SALL4 expression is very rare in endometrial endometrioid and serous carcinoma.
    Hum Pathol. 2024 Oct 24:105675. doi: 10.1016/j.humpath.2024.105675.
    

    >> Share

    
    
26. TABET GC, Zheng L, Hosseini H, Ward J, et al
    Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases.
    Hum Pathol. 2024 Oct 24:105673. doi: 10.1016/j.humpath.2024.105673.
    

    >> Share

    
    
27. DASHTI NK, Swanson AA, Bentz J, Xing D, et al
    DICER1-sarcomas of GYN tract: Expanding on an emerging entity.
    Hum Pathol. 2024;152:105636.
    

    >> Share

    
    September 2024
28. KEENEY M, Keeney GL, Cheville JC, Gupta S, et al
    VHL-mutated papillary cystadenoma of the mesosalpinx with omental tumor deposits and immunophenotypic overlap with mesothelioma.
    Hum Pathol. 2024;151:105617.
    

    >> Share

    
    August 2024
29. NAKAJIMA J, Yano M, Zaitsu S, Kamada K, et al
    Therapeutic indications for antibody-drug conjugates estimated from HER2 and p53 expressions in endometrial carcinoma.
    Hum Pathol. 2024 Aug 16:105649. doi: 10.1016/j.humpath.2024.105649.
    

    >> Share

    
    July 2024
30. ZELISSE HS, Dijk F, van Gent MDJM, Hooijer GKJ, et al
    Improving histotyping precision: the impact of immunohistochemical algorithms on epithelial ovarian cancer classification.
    Hum Pathol. 2024 Jul 29:105631. doi: 10.1016/j.humpath.2024.105631.
    

    >> Share

    
    May 2024
31. NAVARRO SANCHEZ JM, Finkelman BS, Tyburski H, Turner BM, et al
    Performance of HER2 DAKO HercepTest and Ventana 4B5 Immunohistochemical Assays on Detecting HER2 Gene-Amplification in Uterine Serous Carcinomas.
    Hum Pathol. 2024 May 11:S0046-8177(24)00086.
    

    >> Share

    
    April 2024
32. NGO C, Cotteret S, Deneche I, Kfoury M, et al
    Uterine adenosarcoma: clinical significance of histological classification and SNP array analysis.
    Hum Pathol. 2024 Apr 28:S0046-8177(24)00083.
    

    >> Share

    
    
33. GUPTA S, Schoolmeester JK, Cheville JC
    Expanding the Spectrum of Paratesticular Mullerian-Origin Tumors: Adenocarcinoma with Mixed Serous and Endometrioid Features and Clear Cell Carcinoma.
    Hum Pathol. 2024 Apr 27:S0046-8177(24)00060.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share